Orthovisc iyi inogadzirisa kana yakasvibisa sarudzo yepamusoro maserosi, kureva yakanatswa sodium hyaluronate mumuviri wenyama. Hyaluronan, iyo inowanikwa mumuviri womunhu, inogadzirisa zvinyorwa uye inoita sechinhu chinotyisa. Ne osteoarthritis , hutachiona hyaluronan inoshandiswa.
Orthovisc imwe ye hyaluronates inoshandiswa mune imwe nzira inozivikanwa seve viscosupplementation .
Orthovisc haisi yemhuka yakagadzirirwa viscosupplement iyo inoroverwa zvakananga mumabvi ekudzorera kugadzirisa kunamatira uye kugadzirisa zvinhu zvemazuva ose emvura (kureva, synovial fluid ).
Zviratidzo zveOrthovisc
Orthovisc yakagamuchirwa neU.S. Food and Drug Administration (FDA) musi waFebruary 4, 2004, pakurapa marwadzo anokonzerwa nemapfupa eguti muvarwere vakakundikana kuwana ruzivo rwakawanda nekurapa kwakanyanya (semuenzaniso, kurovedza muviri, kurapa muviri) uye kushandiswa kweanorganics dzakashata, dzakadai seacetaminophen .
Orthovisc inonzi inorapwa, kwete mishonga, sezvinoitika kune imwe hyaluronates inoshandiswa muevcosupplementation. Orthovisc inoshandiswa sezvikamu zvitatu kusvika ku 4 majekiseni epra-articular vhiki nevhiki (inopiwa kamwe kamwe pavhiki). Maererano nemugadziri weOrthovisc, inogona kuunza migumisiro inobatsira inopera mavhiki makumi mana.
Contraindications
Vanhu vane hypersensitivity vanozivikanwa kune zvigadzirwa zve hyaluronan havafaniri kurapwa neOrthovisc kana chero ipi zvayo maevcosupplements.
Uyewo, vanhu vanozivikanwa kuti vanoona shiri kana mishonga yemarudzi havafaniri kushandisa Orthovisc. (Cherechedza: Iyi nyevero inoshandiswa kune zvinhu zvose zve hyaluronan.) Vanhu vane utachiona mumabvi akabatanidzwa, zvimwe zvirwere, kana chirwere chepachivara munzvimbo iyo chirwere chinenge chichipiwa hachifaniri kutarisirwa neOrthovisc.
Maitiro Anowirirana Nezviitiko uye Zvakaipa Zviitiko
Zviitiko zvinowanzovhiringidza zvinowanzobatanidzwa neOrthovisc kurapwa munguva dzekuongorora zvipatara zvakasanganisira arthralgia, kurwadziwa shure, uye musoro. Zvimwe zviitiko zvinotambudza zviitiko zvekujairika kwemajw.org.
Kuchengetedza uye Manyevero
Sezvo neipi chero ipi zvayo inoratidzira, inokurudzirwa kuti murwere arege kuita zvinhu zvinotyisa kana mabasa akawanda ekureruka kwemaawa makumi mana. Uyezve, zvinofanira kuonekwa kuti kurwadziwa kana kuvhara kunogona kuitika mushure mejojo, asi kazhinji ichaderera shure kwechinguva chiduku. Zvimwewo zvinokosha, kuchengetedza uye kubudirira kweOrthovisc hazvina kugadziriswa mumadzimai ane pamuviri, vakadzi vanozvidza vana, kana vana.
The Bottom Line
Mamwe maSVC-approved aprescositive, pamwe chete nezuva ravakabvumirwa, anosanganisira:
- Hyalgan 05/28/1997
- Synvisc 08/08/1997
- Supartz 01/24/2001
- Euflexxa 12/03/2004
Sangano reAmerican Association of Orthopedic Surgeons (AAOS) rakati kunyange vamwe varwere vanoridza kusunungurwa kwezviratidzo zveArthritis ne viscosupplementation, chirongwa chacho hachina kumbobvira chiratidzwa kugadzirisa chirwere cheArthritic kana kutizve kuwedzera maronda. Kubudirira kweviscosupplementation mukurapa arthritis hakusi pachena. Izvo zvave zvataurwa kuti viscosupplementation ine mukana wekanakisisa wekushanda kana arthritis iri mumatanho ayo epakutanga (kureva, unyoro kusvika kuenzanisira knee osteoarthritis).
> Sources:
> Orthovisc. Anika Therapeutics.
> Orthovisc Orthovisc High Molecular Hyaluronan . US FDA. Archived Content.
> Orthovisc Patient Information . US FDA.
> Viscosupplementation Treatment for Knee Arthritis. OrthoInfo (AAOS).